An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy

Antigen Incorporated In Virus-like Particles Is Delivered to Specific Dendritic Cell Subsets That Induce An Effective Antitumor Immune Response In Vivo

(2012) Kunyu Li et al.   JOURNAL OF IMMUNOTHERAPY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Virus-like particles: innate immune stimulators

(2011) Ramadevi Raghunandan   Expert Review of Vaccines

Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway

(2011) Stephanie J Win et al.   IMMUNOLOGY AND CELL BIOLOGY

Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7

(2011) Koen Oosterhuis et al.   INTERNATIONAL JOURNAL OF CANCER

Immuno-Therapy with Anti-CTLA4 Antibodies in Tolerized and Non-Tolerized Mouse Tumor Models

(2011) Jonas Persson et al.   PLoS One

A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors

(2011) Darin A. Wick et al.   VACCINE

Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer

(2010) A Wu et al.   GENE THERAPY

High-Resolution Cryo-Electron Microscopy Structures of Murine Norovirus 1 and Rabbit Hemorrhagic Disease Virus Reveal Marked Flexibility in the Receptor Binding Domains

(2010) U. Katpally et al.   JOURNAL OF VIROLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells

(2009) Andrew J. Rech et al.   Annals of the New York Academy of Sciences

Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer

(2009) Christoph Loddenkemper et al.   CANCER SCIENCE

Loss of Epidermal Langerhans Cells Occurs in Human Papillomavirus α, γ, and μ but Not β Genus Infections

(2009) Cheng Mee Leong et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Combination of CTL-associated Antigen-4 Blockade and Depletion of CD25+Regulatory T Cells Enhance Tumour Immunity of Dendritic Cell-based Vaccine in a Mouse Model of Colon Cancer

(2009) Asim Saha et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer

(2008) Duane H. Hamilton et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

(2008) M. J.P. Welters et al.   CLINICAL CANCER RESEARCH

Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects

(2008) S Peng et al.   GENE THERAPY

Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response

(2008) Matthew Peacey et al.   VACCINE

Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells

(2008) Chi-Mu Chuang et al.   VACCINE

Depletion of CD4+CD25+ regulatory T cells can promote local immunity to suppress tumor growth in benzo[a]pyrene-induced forestomach carcinoma

(2008) Yi-Ling Chen et al.   WORLD JOURNAL OF GASTROENTEROLOGY